Our research team focuses on improving successful transplant outcomes by exploring innovative ways to improve transplant health, reduce transplant rejection while concurrently discovering methods to help avoid life-long dependency on rejection-halting immunosuppressive drugs. Our researchers are also actively involved in clinical trials to find new forms of immunosuppression, strategies for reducing complications and new ways to fight post-operative infection.

738

Transplants in 2024

231

Peer-Reviewed Publications in 2024

59

Transplant Faculty with Academic Appointments

Clinical Trials

At Houston Methodist, our dedicated teams of world-renowned researchers help support the mission of our Transplant Research of bringing the latest technologies and advanced treatment options to patients as quickly and safely as possible. 

Explore Our Transplant Research Clinical Trials ➝

Research Highlights
Liver Transplant & Sleeve Gastrectomy Give Hope
Study shows interval-staged liver transplant and sleeve gastrectomy a good option for patients who otherwise wouldn’t qualify for the procedures.  
CD4+ T Cell Immunity Dependent on Stem-Like Program
These findings unravel a stem-like program that controls the self-renewal capacity and effector differentiation potential of CD4+ TEP cells.
Complex Robotic Lung Resection
Using the robot in pneumonectomy, arterioplasty and bronchoplasty to provide information about the technical approach and postoperative management.
headshot of Constance Mobley smiling
Liver Failure Avengers Houston Methodist Researchers First in World
Under the leadership of Constance Mobley, MD, PhD, FACS, researchers have successfully performed a first-in-human miniature liver hepatocyte transplant to change a patient’s lymph nodes into ectopic miniature livers.
TOP